Tranexamic acid to reduce postpartum hemorrhage: A MANDATE systematic review and analyses of impact on maternal mortality

American Journal of Perinatology

Volumn 32, Issue 5, 2015, Pages 469-474

  McClure, Elizabeth M ^a   Jones, Bonnie ^a   Rouse, Doris J ^a   Griffin, Jennifer B ^a   Kamath Rayne, Beena D ^b   Downs, Allan ^a   Goldenberg, Robert L ^c  

^a RTI INTERNATIONAL   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c Department of Research Computing Division Research Triangle Institute ^*  (United States)

Author keywords

maternal mortality; postpartum hemorrhage; sub Saharan Africa; tranexamic acid

Indexed keywords

TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

AFRICA SOUTH OF THE SAHARA; ARTICLE; BIRTH RATE; CESAREAN SECTION; DISEASE SEVERITY; DRUG EFFICACY; DRUG UTILIZATION; FEMALE; HEALTH CENTER; HOME DELIVERY; HOSPITAL; HUMAN; MATERNAL MORTALITY; MATHEMATICAL MODEL; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; PROPHYLAXIS; SYSTEMATIC REVIEW; DEVELOPING COUNTRY; MORTALITY; PREGNANCY; THEORETICAL MODEL;

AFRICA SOUTH OF THE SAHARA; ANTIFIBRINOLYTIC AGENTS; BIRTH RATE; COMMUNITY HEALTH CENTERS; DEVELOPING COUNTRIES; FEMALE; HUMANS; MATERNAL MORTALITY; MODELS, THEORETICAL; POSTPARTUM HEMORRHAGE; PREGNANCY; TRANEXAMIC ACID;

EID: 84927597826     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0034-1390347     Document Type: Article

References (41)

1. Khan K. S., Wojdyla D., Say L., Gülmezoglu A. M., Van Look P. F. WHO analysis of causes of maternal death: a systematic review. Lancet: 2006; 367 9516 1066 1074
2. Beltman J., VAN DEN Akker T., VAN Lonkhuijzen L., Schmidt A., Chidakwani R., VAN Roosmalen J. Beyond maternal mortality: obstetric hemorrhage in a Malawian district. Acta Obstet Gynecol Scand: 2011; 90 12 1423 1427
3. Darmstadt G. L., Lee A. C., Cousens S., et al. 60 Million non-facility births: who can deliver in community settings to reduce intrapartum-related deaths? Int J Gynaecol Obstet: 2009; 107 01 S89 S112
4. Roberts I., Ker K. Tranexamic acid for postpartum bleeding. Int J Gynaecol Obstet: 2011; 115 3 220 221
5. Shakur H., Elbourne D., Gülmezoglu M., et al. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials: 2010; 11 40
6. Shakur H., Roberts I., Bautista R., et al. CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet: 2010; 376 9734 23 32
7. Roberts I., Shakur H., Afolabi A., et al. CRASH-2 collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet: 2011; 377 9771 1096 1101, e1-e2
8. World Health Organization. Summary of the report of the 18th meeting of the WHO Expert Committee on the Selection and Use of Essential Medicines. March 21-25, 2011; Accra, Ghana. Available at: http://www.who.int/selection-medicines/committees/expert/18/en/index.html
9. Guerriero C., Cairns J., Perel P., Shakur H., Roberts I.; CRASH 2 trial collaborators. Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS ONE: 2011; 6 5 e18987
10. Freeman E. W., Lukes A., VanDrie D., Mabey R. G., Gersten J., Adomako T. L. A dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleeding. Am J Obstet Gynecol: 2011; 205 4 e1 e7
11. Ducloy-Bouthors A. S., Jude B., Duhamel A., et al. EXADELI Study Group. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care: 2011; 15 2 R117
12. de Guzman R., Polykratis I. A., Sondeen J. L., Darlington D. N., Cap A. P., Dubick M. A. Stability of tranexamic acid after 12-week storage at temperatures from -20°c to 50°c. Prehosp Emerg Care: 2013; 17 3 394 400
13. Gungorduk K., Aslcloʇlu O., Ylldlrlm G., Ark C., Tekirdaʇ A. I., Beslmoglu B. Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. Am J Perinatol: 2013; 30 5 407 413
14. Movafegh A., Eslamian L., Dorabadi A. Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery. Int J Gynaecol Obstet: 2011; 115 3 224 226
15. Peitsidis P., Kadir R. A. Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum. Expert Opin Pharmacother: 2011; 12 4 503 516
16. Sekhavat L., Tabatabaii A., Dalili M., Farajkhoda T., Tafti A. D. Efficacy of tranexamic acid in reducing blood loss after cesarean section. J Matern Fetal Neonatal Med: 2009; 22 1 72 75
17. Xu J., Gao W., Ju Y. Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial. Arch Gynecol Obstet: 2013; 287 3 463 468
18. Shahid A., Khan A. Tranexamic acid in decreasing blood loss during and after caesarean section. J Coll Physicians Surg Pak: 2013; 23 7 459 462
19. Abdel-Aleem H., Alhusaini T. K., Abdel-Aleem M. A., Menoufy M., Gülmezoglu A. M. Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. J Matern Fetal Neonatal Med: 2013; 26 17 1705 1709
20. Sentürk M. B., Cakmak Y., Yildiz G., Yildiz P. Tranexamic acid for cesarean section: a double-blind, placebo-controlled, randomized clinical trial. Arch Gynecol Obstet: 2013; 287 4 641 645
21. McClure E. M., Rouse D. J., Macguire E. R., et al. The MANDATE model for evaluating interventions to reduce postpartum hemorrhage. Int J Gynaecol Obstet: 2013; 121 1 5 9
22. Rudan I., Gibson J., Kapiriri L., et al. Child Health and Nutrition Research Initiative (CHNRI). Setting priorities in global child health research investments: assessment of principles and practice. Croat Med J: 2007; 48 5 595 604
23. Goudar S. S., Carlo W. A., McClure E. M., et al. The Maternal and Newborn Health Registry Study of the Global Network for Women's and Children's Health Research. Int J Gynaecol Obstet: 2012; 118 3 190 193
24. Klufio C. A., Amoa A. B., Kariwiga G. Primary postpartum haemorrhage: causes, aetiological risk factors, prevention and management. P N G Med J: 1995; 38 2 133 149
25. Dildy G. A. III. Postpartum hemorrhage: new management options. Clin Obstet Gynecol: 2002; 45 2 330 344
26. Rath W. H. Postpartum hemorrhage-update on problems of definitions and diagnosis. Acta Obstet Gynecol Scand: 2011; 90 5 421 428
27. Flandermeyer D., Stanton C., Armbruster D. Uterotonic use at home births in low-income countries: a literature review. Int J Gynaecol Obstet: 2010; 108 3 269 275
28. MANDATE model; Available at: http://mnhtech.org (Accessed November 15, 2013)
29. Novikova N., Hofmeyr G. J. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev: 2010; 7 CD007872
30. Ferrer P., Roberts I., Sydenham E., Blackhall K., Shakur H. Anti-fibrinolytic agents in post partum haemorrhage: a systematic review. BMC Pregnancy Childbirth: 2009; 9 29
31. Gai M. Y., Wu L. F., Su Q. F., Tatsumoto K. Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial. Eur J Obstet Gynecol Reprod Biol: 2004; 112 2 154 157
32. Cook L., Roberts I.; WOMAN Trial Collaborators. Post-partum haemorrhage and the WOMAN trial. Int J Epidemiol: 2010; 39 4 949 950
33. As A. K., Hagen P., Webb J. B.; AK. Tranexamic acid in the management of postpartum haemorrhage. Br J Obstet Gynaecol: 1996; 103 12 1250 1251
34. Cook L., Roberts I.; WOMAN Trial Collaborators. Post-partum haemorrhage and the WOMAN trial. Int J Epidemiol: 2010; 39 4 949 950
35. de Lange N. M., Lancé M. D., de Groot R., Beckers E. A., Henskens Y. M., Scheepers H. C. Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. Obstet Gynecol Surv: 2012; 67 7 426 435
36. Onwuemene O., Green D., Keith L. Postpartum hemorrhage management in 2012: predicting the future. Int J Gynaecol Obstet: 2012; 119 1 3 5
37. Bonnet M. P., Basso O. Prohemostatic interventions in obstetric hemorrhage. Semin Thromb Hemost: 2012; 38 3 259 264
38. Dunn C. J., Goa K. L. Tranexamic acid: a review of its use in surgery and other indications. Drugs: 1999; 57 6 1005 1032
39. Sapire K. E. A study of bleeding patterns with two injectable contraceptives given postpartum and the effect of two non-hormonal treatments. Adv Contracept: 1991; 7 4 379 387
40. Astedt B. Clinical pharmacology of tranexamic acid. Scand J Gastroenterol Suppl: 1987; 137 22 25
41. Kapungu C. T., Mensah-Homiah J., Akosah E., et al. Ghana PPH Study Group. A community-based continuum of care model for the prevention of postpartum hemorrhage in rural Ghana. Int J Gynaecol Obstet: 2013; 120 2 156 159